市場調査レポート

商品コード

1623666

リンパ浮腫治療市場規模、シェア、成長分析、治療タイプ別、患部別、年齢層別、投与経路別、流通チャネル別、エンドユーザー別、地域別-産業別予測、2025～2032年

Lymphedema Treatment Market Size, Share, Growth Analysis, By Treatment Type, By Type, By Affected Area, By Age Group, By Route Of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

出版日: 2024年12月25日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

リンパ浮腫治療市場規模は2023年に8億6,014万米ドルと評価され、2024年の9億4,185万米ドルから2032年には19億22万米ドルに成長し、予測期間（2025～2032年）のCAGRは9.5%で成長する展望です。

リンパ浮腫治療市場は、乳がん罹患率の上昇やがん生存者におけるリンパ浮腫の蔓延など、いくつかの要因によって大きな成長を遂げています。特に、乳がん治療を受けた女性の40％がリンパ浮腫を発症しており、これは治療後すぐに現れることもあれば、数十年後に現れることもあります。この疾患は主に下肢に影響を及ぼし、婦人科がん患者の発症率が高いです。効果的なリンパ浮腫治療ソリューションに対する需要は、主要な市場参入企業による技術の進歩や製品の革新によっても促進されています。リンパ浮腫の衰弱を経験する患者、特に手術後の患者が多い中、最先端のがん治療法の継続的な開発は、この症状を緩和し、市場機会を拡大する上で極めて重要です。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主要市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
製品ポートフォリオ分析
セグメント別シェア分析
収益の前年比比較（2022～2024）

主要企業プロファイル

Bio Compression Systems
Tactile Medical
Medi
Lympha Press
Sigvaris
BSN Medical
L&R USA Inc.
Devon Medical Products
3M Health Care
JOBST USA
Thuasne
Wright Therapy Products
BioHorizons IPH, Inc.
Haddenham Healthcare
ArjoHuntleigh
Paul Hartmann
Bioventus
Baxter International Inc.
CircAid Medical Products, Inc.
Essity Aktiebolag

結論と推奨事項

Product Code: SQMIG35G2213

Lymphedema Treatment Market size was valued at USD 860.14 Million in 2023 and is poised to grow from USD 941.85 Million in 2024 to USD 1900.22 Million by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The lymphedema treatment market is experiencing significant growth, driven by several factors including the rising incidence of breast cancer and the prevalence of lymphedema among cancer survivors. Notably, 40% of women undergoing breast cancer treatment develop lymphedema, which can manifest soon after treatment or even decades later. The disorder primarily affects the lower extremities and has higher occurrences among gynecologic cancer patients. The demand for effective lymphedema treatment solutions is also fueled by advancements in technology and product innovation from major market players. With a substantial patient population experiencing lymphedema's debilitating effects, particularly post-surgery, ongoing development of cutting-edge cancer therapies is critical to mitigating this condition and expanding market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lymphedema Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lymphedema Treatment Market Segmental Analysis

Global Lymphedema Treatment Market is segmented by treatment type, type, affected area, age group, route of administration, distribution channel, end user and region. Based on treatment type, the market is segmented intoCompression Therapy, surgery, drug therapy, laser therapy and others. Based on type, the market is segmented into secondary lymphedema and primary lymphedema. Based on affected area, the market is segmented into lower extremity, upper extremity and genitalia. Based on age group, the market is segmented into adult, geriatric and pediatric. Based on route of administration, the market is segmented into oral, injectable and topical. Based on distribution channel, the market is segmented into pharmacy stores, direct tender and others. Based on end user, the market is segmented into hospital, speciality clinics, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lymphedema Treatment Market

The lymphedema treatment market is expected to grow significantly due to the rising incidence of lymphedema and breast cancer. An increase in cancer cases presents vast opportunities for market expansion. Coupled with surging health expenditures and heightened investments in drug discovery and development, demand for healthcare facilities is on the rise. Furthermore, the anticipated emergence of innovative lymphedema treatment options is likely to drive market growth during the forecast period. Technological advancements in treatment methodologies will also contribute to this upward trend. Additionally, government initiatives and favorable reimbursement policies are set to support the market's expansion.

Restraints in the Lymphedema Treatment Market

The Lymphedema Treatment market faces notable restraints that may hinder its growth. Despite technological advancements in the field, there remains no definitive cure for lymphedema, which poses a significant challenge to market development. Furthermore, the considerable expenses associated with various procedures and treatment options are anticipated to deter potential patients and healthcare providers, ultimately affecting overall market expansion. The combination of the lack of a permanent solution and the financial burden of managing lymphedema underscores the need for continued research and innovation to address these limitations and improve patient access to effective treatments.

Market Trends of the Lymphedema Treatment Market

The lymphedema treatment market is poised for significant growth, driven by an increasing prevalence of the condition and expanding awareness among healthcare providers and patients. Innovative therapies and advanced technologies are emerging at a rapid pace, enhancing treatment efficacy and patient safety. Rising healthcare expenditures globally are further propelling market expansion, alongside ongoing advancements in healthcare innovation that focus on personalized treatment options. Additionally, pharmaceutical companies are introducing cutting-edge medical devices, which are not only improving treatment outcomes but also stimulating market dynamics on a global scale, thereby positioning the lymphedema treatment market for sustained growth in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Lymphedema Treatment Market Size by Treatment Type & CAGR (2025-2032)

Market Overview
Compression Therapy
Surgery
Drug Therapy
Laser Therapy
Others

Global Lymphedema Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Secondary Lymphedema
Primary Lymphedema

Global Lymphedema Treatment Market Size by Affected Area & CAGR (2025-2032)

Market Overview
Lower Extremity
Upper Extremity
Genitalia

Global Lymphedema Treatment Market Size by Age Group & CAGR (2025-2032)

Market Overview
Adult
Geriatric
Pediatric

Global Lymphedema Treatment Market Size by Route Of Administration & CAGR (2025-2032)

Market Overview
Oral
Injectable
Topical

Global Lymphedema Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Pharmacy Stores
Direct Tender
Others

Global Lymphedema Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospital
Speciality Clinics
Ambulatory Surgical Centers
Others

Global Lymphedema Treatment Market Size & CAGR (2025-2032)

North America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- US
- Canada
Europe (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Bio Compression Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tactile Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lympha Press
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigvaris
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BSN Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
L&R USA Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devon Medical Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Health Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JOBST USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thuasne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Therapy Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioHorizons IPH, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haddenham Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArjoHuntleigh
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paul Hartmann
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CircAid Medical Products, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essity Aktiebolag
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

リンパ浮腫治療市場規模、シェア、成長分析、治療タイプ別、患部別、年齢層別、投与経路別、流通チャネル別、エンドユーザー別、地域別-産業別予測、2025～2032年

Lymphedema Treatment Market Size, Share, Growth Analysis, By Treatment Type, By Type, By Affected Area, By Age Group, By Route Of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と展望

主要市場の考察

リンパ浮腫治療市場規模：治療タイプ別&CAGR（2025～2032年）

リンパ浮腫治療市場規模：タイプ別&CAGR（2025～2032年）

リンパ浮腫治療市場規模：疾患部位別&CAGR（2025～2032年）

リンパ浮腫治療市場規模：年齢層別&CAGR（2025～2032年）

リンパ浮腫治療市場規模：投与経路別&CAGR（2025～2032年）

リンパ浮腫治療市場規模：流通チャネル別&CAGR（2025～2032年）

リンパ浮腫治療市場規模：エンドユーザー別&CAGR（2025～2032年）

リンパ浮腫治療市場規模&CAGR（2025～2032年）